Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HER-2 Positive Advanced Gastric Cancer × HM781-36B × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 5 NSCLC 3 Squamous Cell Carcinoma of Head and Neck 2 Carcinoma, Non-Small-Cell Lung 2 Adenocarcinoma of Lung 2 Recurrence 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 HER-2 Positive Advanced Gastric Cancer 1 Advanced Solid Tumor 1 Advanced Solid Malignancies 1

Interventions

Trastuzumab 1 Paclitaxel 1 HM781-36B 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01746771 2016-03-03

A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer

Hanmi Pharmaceutical Company Limited

Phase 1/2 Completed

Gastrointestinal

HER-2 Positive Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡